Qiagen reaches biological sample milestone

By The Science Advisory Board staff writers

August 24, 2021 -- Qiagen's consumables kits have now been used to process more than 3 billion biological samples. Furthermore, the company's next-generation sequencing assays have been utilized to test 1 million samples since 2015.

Qiagen said that sample technology is one of its five pillars of growth, along with its Quantiferon immune-response technology, NeuMoDx integrated polymerase chain reaction (PCR) system, QIAstat-Dx syndromic testing system, and QIAcuity digital PCR portfolio.

If you like this content, please share it with a colleague!

Related Reading

Qiagen reports sales increases for Q2
Qiagen announced sales increases in its financial report for the second quarter of 2021.

Qiagen launches workflow configurator
Netherlands-based sample and assay technology provider Qiagen announced it has launched a cloud-based workflow tool to help researchers simplify and optimize...

Qiagen and Sysmex form strategic alliance
Qiagen announced it has entered a strategic alliance with partner Sysmex for the development and commercialization of next-generation sequencing products...

Qiagen launches CRISPR products to aid in edited genetic material analysis
Qiagen has rolled out its QIAprep & CRISPR Kit and CRISPR Q-Primer Solutions. The products are intended to support researchers in analyzing edited...

Qiagen posts strong sales, earnings growth in Q1
Strong growth in both COVID-19 and non-COVID-19 product groups propelled Qiagen to a 48% increase in net sales at constant exchange rates in its first...